The single-use bioreactors market will grow at a 18.8% CAGR in the years to come, and will reach to a value of USD 13,595.9 million by 2030. The growth of the industry is powered by the increasing prevalence of infectious and chronic diseases.
 |
| To learn more about this report: https://bit.ly/3NZBbmV |
There has been a significant increase in the number of infectious diseases worldwide. The COVID-19 pandemic has led to the rapid adoption of advanced technologies by life sciences and biopharmaceutical firms to produce vaccines quickly and on a large scale.
This has brought about a growing demand for single-use systems, which are flexible and modular, allowing for local manufacturing facilities in emerging nations that lack investments. These systems are mainly utilized in the production of viral vaccines.
To better understand the COVID-19 virus's behavior in humans, some manufacturers are using bioreactors to cultivate suitable host cells. Additionally, several companies have entered in collaborations to enhance their market positions.
North America dominates the single-use bioreactors market due to factors like the high prevalence of chronic diseases, presence of top players, advanced healthcare facilities, technological advancements and strong research and development initiatives.
Within North America, the U.S. plays a significant role, driven by the adoption of innovative technologies, public awareness regarding disease prevention, government support, and advanced healthcare infrastructure.
The vaccines category had the largest revenue share in 2022 due to the increase in infectious diseases. The demand for mass production of vaccines for prevention and treatment purposes has increased. The COVID-19 pandemic further accelerated vaccine manufacturing, leading to the adoption of single-use bioreactors.
Lab-scale production is leading the industry. This is due to the fact that the biopharma industry requires the frequent use of bioreactors for various preclinical and clinical research purposes.
Moreover, the increasing acceptance and progressions in single-use technologies will all boost the expansion of the industry, a great deal in the future.
It is because of the increasing research and development activities in the medical industry, that the demand for single-use bioreactors will continue to rise in the years to come.
